Close

More on AGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (3.5 Score)
- Holders
- Dividends (1.5% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (N/A)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AGN Cash Flow Statement

Click line-items for a historical chart and %
Cash flows from operating activities:
Net earnings 1.53B
Non-cash items included in net earnings:
Depreciation and amortization
Amortization of original issue discount and debt issuance costs 2.8M
Amortization of net realized gain on interest rate swap -15M
Deferred income tax benefit
(Gain) loss on disposal and impairment of assets 29.8M
Unrealized loss (gain) on derivative instruments -37.2M
Expense of share-based compensation plans 159.7M
Intangible asset impairment
Expense from changes in fair value of contingent consideration
Restructuring charges
Gain on investments, net 3.1M
Changes in operating assets and liabilities:
Trade receivables -115.7M
Inventories -43.8M
Other current assets
Other non-current assets
Accounts payable 1.9M
Accrued expenses 115.9M
Income taxes -124M
Other liabilities
Net cash provided by operating activities 1.93B
Cash flows from investing activities:
Purchases of short-term investments -1.27B
Acquisitions, net of cash acquired -67.5M
Additions to property, plant and equipment -243.9M
Additions to capitalized software -19M
Contractual purchase price adjustment to prior acquisition
Proceeds from maturities of short-term investments
Proceeds from sale of investments
Proceeds from sale of property, plant and equipment 500K
Net cash provided by (used in) investing activities 182.7M
Cash flows from financing activities:
Repayments of convertible borrowings
Dividends to stockholders -59.6M
Payments to acquire treasury stock -839.2M
Payments of contingent consideration -10.2M
Net borrowings (repayments) of notes payable 16.5M
Sale of stock to employees 521M
Excess tax benefits from share-based compensation 167.5M
Net cash used in financing activities -204M
Effect of exchange rate changes on cash and equivalents -41.2M
Net (decrease) increase in cash and equivalents 1.87B
Cash and equivalents at beginning of period 3.05B
Cash and equivalents at end of period 4.91B
Cash paid for:
Interest (net of amount capitalized) 83.4M
Income taxes, net of refunds 487.8M

Entities mentioned with AGN

View All Entities